Published in Biol Psychiatry on August 01, 1986
Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol (2008) 1.99
Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front Psychiatry (2014) 0.99
Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci (2010) 0.98
Regional alterations in purkinje cell density in patients with autism. PLoS One (2014) 0.92
No change in neuron numbers in the dentate nucleus of patients with schizophrenia estimated with a new stereological method--the smooth fractionator. J Anat (2004) 0.78
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07
Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Late-onset schizophrenia: an overview. Schizophr Bull (1988) 2.58
Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53
Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19
Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry (2000) 2.04
Enhancing informed consent for research and treatment. Neuropsychopharmacology (2001) 2.04
Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 2.01
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91
Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry (1995) 1.88
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry (1999) 1.86
Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand (2006) 1.75
Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry (1989) 1.69
Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand (2002) 1.63
New-onset psychosis in HIV-infected patients. J Clin Psychiatry (1991) 1.62
Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry (1994) 1.55
Physical comorbidity and polypharmacy in older psychiatric patients. Biol Psychiatry (1994) 1.54
Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry (1999) 1.49
Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc (1996) 1.46
The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatr Serv (1999) 1.45
Late-onset psychosis with somatic delusions. Psychosomatics (1994) 1.45
Geriatric psychiatry may be the mainstream psychiatry of the future. Am J Psychiatry (2000) 1.40
Late-onset psychosis: clinical, research, and ethical considerations. Am J Psychiatry (1999) 1.37
The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc (1995) 1.31
Psychophysiologic therapy based on the concepts of Patanjail. A new approach to the treatment of neurotic and psychosomatic disorders. Am J Psychother (1973) 1.28
Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol (1998) 1.22
Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry (1989) 1.21
Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry (1999) 1.18
Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc (1999) 1.18
Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry (2001) 1.16
Schizoaffective disorder: a form of schizophrenia or affective disorder? J Clin Psychiatry (1999) 1.13
Did schizophrenia exist before the eighteenth century? Compr Psychiatry (1986) 1.11
Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry (2001) 1.08
Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry (1993) 1.07
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry (2003) 1.07
Reduced Purkinje cell density in Huntington's disease. Exp Neurol (1984) 1.06
High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry (1989) 1.05
New pathway for delta-aminolevulinic acid biosynthesis: formation from alpha-ketoglutaric acid by two partially purified plant enzymes. Biochem Biophys Res Commun (1976) 1.03
Self-reported social functioning among older patients with schizophrenia. Schizophr Res (1997) 1.02
The first Summer Research Institute in Geriatric Psychiatry. Am J Geriatr Psychiatry (1997) 1.01
Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry (1997) 1.00
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
Treatment costs and use of community mental health services for schizophrenia by age cohorts. Am J Psychiatry (1996) 0.98
Older patients with schizophrenia: challenges in the coming decades. Psychiatr Serv (1999) 0.98
Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry (2000) 0.98
Correlates of functional status in older patients with schizophrenia. Psychiatry Res (1998) 0.98
Gender, estrogen, and schizophrenia. Psychopharmacol Bull (1997) 0.97
Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res (2001) 0.96
Neuroanatomical studies of major affective disorders. A review and suggestions for further research. Br J Psychiatry (1988) 0.96
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry (2000) 0.95
Quality of well-being in late-life psychosis. Psychiatry Res (1996) 0.95
Impairment of the semantic network in schizophrenia. Psychiatry Res (1996) 0.95
Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry (1995) 0.93
Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull (1988) 0.93
Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res (2001) 0.93
Changing epidemiology of tardive dyskinesia: an overview. Am J Psychiatry (1981) 0.93
Tardive dyskinesia--reversible and persistent. Arch Gen Psychiatry (1979) 0.93
Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull (1992) 0.93
Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study. Curr Pharmacogenomics Person Med (2009) 0.92
Decision-making capacity for informed consent in the older population. Bull Am Acad Psychiatry Law (1995) 0.92
A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr Scand (2001) 0.92
HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. Am J Psychiatry (1994) 0.92
Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging (2000) 0.91
Accelerated age-related decline in processing resources in schizophrenia: evidence from pupillary responses recorded during the span of apprehension task. J Int Neuropsychol Soc (2000) 0.91
Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders. Psychol Med (2007) 0.91
A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia. Schizophr Res (2002) 0.91
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Psychopharmacology (Berl) (1997) 0.91
Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. J Psychother Pract Res (2000) 0.90
Direct assessment of functional status in older patients with schizophrenia. Am J Psychiatry (1997) 0.90
Alzheimer's disease and its management in the year 2010. Psychiatr Serv (1999) 0.90
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand (1994) 0.90
Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol (1999) 0.90
Pupillary responses index overload of working memory resources in schizophrenia. J Abnorm Psychol (1997) 0.89
Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients. J Geriatr Psychiatry Neurol (1999) 0.89
Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc (2000) 0.89
Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry (1999) 0.89
Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E. Ann N Y Acad Sci (1989) 0.88
Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand (1987) 0.88
Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases. J Neuropsychiatry Clin Neurosci (1992) 0.88
Antipsychotics. Clin Geriatr Med (1990) 0.87
Biological research in geriatric psychiatry. Biol Psychiatry (1991) 0.87
The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv (2000) 0.87
Geriatric psychosis. Psychiatr Q (1997) 0.87
Sensorimotor disinhibition in Parkinson's disease: effects of levodopa. Ann Neurol (1992) 0.87
Serendipity in biological psychiatry--a myth? Arch Gen Psychiatry (1979) 0.87
Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry (2000) 0.86
A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biol Psychiatry (1994) 0.85
Therapeutic strategies against tardive dyskinesia. Two decades of experience. Arch Gen Psychiatry (1982) 0.85
Neurobehavioral and neurodiagnostic aspects of late-onset psychosis. Arch Clin Neuropsychol (1994) 0.84
Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology. Psychophysiology (1998) 0.84
Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment. J Affect Disord (1997) 0.83
Hippocampal pyramidal cells and aging in the human: a quantitative study of neuronal loss in sectors CA1 to CA4. Exp Neurol (1986) 0.83